|
|
Blood, 1 April 2005, Vol. 105, No. 7, pp. 2671-2676.
Prepublished online as a Blood First Edition Paper on December 2, 2004; DOI 10.1182/blood-2004-09-3509.
Previous Article | Next Article 
Submitted September 9, 2004
Accepted November 26, 2004
Genetic complementation reveals a novel human congenital disorder of glycosylation of type II, due to inactivation of the Golgi CMP-sialic acid transporter
Ivan Martinez-Duncker*, Thierry Dupre, Veronique Piller, Friedrich Piller, Jean-Jacques Candelier, Catherine Trichet, Gil Tchernia, Rafael Oriol, and Rosella Mollicone
INSERM U504, GDR CNRS 2590, University of Paris Sud XI, Villejuif, France
Laboratoire de biochimie A, Hopital Bichat, Claude Bernard AP-HP, Paris, France
Laboratoire de biochimie A, Centre de Biophysique Moleculaire-CNRS UPR4301, Orleans, France
Laboratoire d'Hematologie, Immunologie et Cytogenetique, Hopital Kremlin-Bicetre, Kremlin-Bicetre, France
* Corresponding author; email: martinez{at}vjf.inserm.fr.
We have identified a homozygous G >A substitution in the donor splice site of the intron 6 (IVS6+1G >A) of the CMP-sialic acid transporter gene of Lec2 cells, as the mutation responsible for their asialo-phenotype. These cells were used in complementation studies, to test the activity of the two CMP-sialic acid transporter cDNA alleles of a patient devoid of sialyl-Lex expression on polymorphonuclear cells. No complementation was obtained with either of the two patient alleles, whereas full restoration of the sialylated phenotype was obtained in the Lec2 cells transfected with the corresponding human wild type transcript. The inactivation of one patient allele, by a double microdeletion inducing a premature stop codon at position 327, and a splice mutation of the other allele inducing a 130 bp deletion and a premature stop codon at position 684, are proposed to be the causal defects of this disease. A four base insertion in the intron 6 was found in the mother and is proposed to be responsible for the splice mutation. We conclude that this defect is a new type of congenital disorder of glycosylation (CDG) of type IIf, affecting the transport of CMP-sialic acid into the Golgi.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Crispin, V. T. Chang, D. J. Harvey, R. A. Dwek, E. J. Evans, D. I. Stuart, E. Y. Jones, J. M. Lord, R. A. Spooner, and S. J. Davis
A Human Embryonic Kidney 293T Cell Line Mutated at the Golgi {alpha}-Mannosidase II Locus
J. Biol. Chem.,
August 7, 2009;
284(32):
21684 - 21695.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Jamroz, D. Adamek, J. Paprocka, M. Adamowicz, E. Marszal, and R. A. Wevers
CDG Type Ia and Congenital Cytomegalovirus Infection: Two Coexisting Conditions
J Child Neurol,
January 1, 2009;
24(1):
13 - 18.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Miyazaki, K. Angata, P. H. Seeberger, O. Hindsgaul, and M. Fukuda
CMP substitutions preferentially inhibit polysialic acid synthesis
Glycobiology,
February 1, 2008;
18(2):
187 - 194.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Perez-Cerda, D. Quelhas, A. I. Vega, J. Ecay, L. Vilarinho, and M. Ugarte
Screening Using Serum Percentage of Carbohydrate-Deficient Transferrin for Congenital Disorders of Glycosylation in Children with Suspected Metabolic Disease
Clin. Chem.,
January 1, 2008;
54(1):
93 - 100.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Wopereis, S. Grunewald, K. M.L.C. Huijben, E. Morava, R. Mollicone, B. G.M. van Engelen, D. J. Lefeber, and R. A. Wevers
Transferrin and Apolipoprotein C-III Isofocusing Are Complementary in the Diagnosis of N- and O-Glycan Biosynthesis Defects
Clin. Chem.,
February 1, 2007;
53(2):
180 - 187.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Zhao, T.-L. L. Chen, B. M. Vertel, and K. J. Colley
The CMP-sialic Acid Transporter Is Localized in the Medial-Trans Golgi and Possesses Two Specific Endoplasmic Reticulum Export Motifs in Its Carboxyl-terminal Cytoplasmic Tail
J. Biol. Chem.,
October 13, 2006;
281(41):
31106 - 31118.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Johnson and E. S. Bennett
Isoform-specific Effects of the beta2 Subunit on Voltage-gated Sodium Channel Gating
J. Biol. Chem.,
September 8, 2006;
281(36):
25875 - 25881.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Thiel, T. Lubke, G. Matthijs, K. von Figura, and C. Korner
Targeted Disruption of the Mouse Phosphomannomutase 2 Gene Causes Early Embryonic Lethality
Mol. Cell. Biol.,
August 1, 2006;
26(15):
5615 - 5620.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. D. Cohn, E. Eklund, A. L. Bergner, J. F. Casella, S. L. Woods, J. Althaus, K. J. Blakemore, H. E. Fox, J. E. Hoover-Fong, A. Hamosh, et al.
Intracranial Hemorrhage as the Initial Manifestation of a Congenital Disorder of Glycosylation
Pediatrics,
August 1, 2006;
118(2):
e514 - e521.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Helmus, J. Denecke, S. Yakubenia, P. Robinson, K. Luhn, D. L. Watson, P. J. McGrogan, D. Vestweber, T. Marquardt, and M. K. Wild
Leukocyte adhesion deficiency II patients with a dual defect of the GDP-fucose transporter
Blood,
May 15, 2006;
107(10):
3959 - 3966.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Wopereis, D. J. Lefeber, E. Morava, and R. A. Wevers
Mechanisms in Protein O-Glycan Biosynthesis and Clinical and Molecular Aspects of Protein O-Glycan Biosynthesis Defects: A Review
Clin. Chem.,
April 1, 2006;
52(4):
574 - 600.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Thomsen, P. Horn, F. Panitz, E. Bendixen, A. H. Petersen, L.-E. Holm, V. H. Nielsen, J. S. Agerholm, J. Arnbjerg, and C. Bendixen
A missense mutation in the bovine SLC35A3 gene, encoding a UDP-N-acetylglucosamine transporter, causes complex vertebral malformation
Genome Res.,
January 1, 2006;
16(1):
97 - 105.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Wopereis, E. Morava, S. Grunewald, M. Adamowicz, K. M. L. C. Huijben, D. J. Lefeber, and R. A. Wevers
Patients with unsolved congenital disorders of glycosylation type II can be subdivided in six distinct biochemical groups
Glycobiology,
December 1, 2005;
15(12):
1312 - 1319.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|